First Horizon Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-601
Closed -$5.69K 2376
2025
Q1
$5.69K Hold
601
﹤0.01% 1779
2024
Q4
$6.76K Sell
601
-46
-7% -$808 ﹤0.01% 1730
2024
Q3
$18.3K Buy
647
+45
+7% +$1.16K ﹤0.01% 1395
2024
Q2
$11.5K Sell
602
-31
-5% -$792 ﹤0.01% 1478
2024
Q1
$20.8K Buy
633
+614
+3,232% +$19.6K ﹤0.01% 1330
2023
Q4
$627 Buy
+19
New +$538 ﹤0.01% 2280
2023
Q3
Sell
-188
Closed -$5.7K 2432
2023
Q2
$5.7K Buy
188
+41
+28% +$1.33K ﹤0.01% 1759
2023
Q1
$4.77K Buy
+147
New +$4.65K ﹤0.01% 1829
2020
Q2
Sell
-591
Closed -$3K 1405
2020
Q1
$3K Hold
591
﹤0.01% 1196
2019
Q4
$5K Hold
591
﹤0.01% 1265
2019
Q3
$4K Hold
591
﹤0.01% 1296
2019
Q2
$4K Hold
591
﹤0.01% 1308
2019
Q1
$7K Hold
591
﹤0.01% 1149
2018
Q4
$11K Hold
591
﹤0.01% 983
2018
Q3
$16K Hold
591
﹤0.01% 956
2018
Q2
$12K Hold
591
﹤0.01% 1049
2018
Q1
$9K Hold
591
﹤0.01% 1031
2017
Q4
$8K Buy
591
+372
+170% +$5.24K ﹤0.01% 1092
2017
Q3
$4K Hold
219
﹤0.01% 1214
2017
Q2
$3K Buy
+219
New +$5.27K ﹤0.01% 1241

Other funds holding EVH

First Horizon Advisors's EVH Position: Q2 2025 in Review

First Horizon Advisors sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 601 shares — an estimated $5.69K sold.

First Horizon Advisors first reported a position in EVH in Q2 2017 and held it in 20 quarters. The position peaked at $20.8K in Q1 2024. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • First Horizon Advisors reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • First Horizon Advisors sold 601 Evolent Health shares in Q2 2025, an estimated $5.69K.
  • First Horizon Advisors first reported a position in Evolent Health in Q2 2017 and held it in 20 quarters.
  • First Horizon Advisors's Evolent Health position peaked at $20.8K in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.